NCT06898099

Brief Summary

In France, the treatment of chronic insomnia relies mainly on hypnotic drugs in routine care, despite the high level of iatrogenicity. Cognitive-behavioral therapy (CBT) is recommended by the HAS as a non-pharmaceutical first-line therapy for chronic insomnia. Despite evidence of their efficacy in chronic insomnia, these therapies remain underdeveloped in France (few practitioners, time-consuming for the patient). Hypnotherapy is another non-drug intervention suitable for routine outpatient care. Among the hypnosis methods practiced in France, E2R (Emotion, Regression, Repair) is a hypnotherapy method used in general practice, particularly for chronic insomnia. To date, no clinical trials have been carried out to demonstrate its effectiveness in this pathology. The HypERR study is a multicenter, randomized, open-label study designed to evaluate the efficacy of a hypotherapy method called E2R in the management of chronic insomnia, by comparing it with standard care (without hypnosis).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
11mo left

Started Oct 2025

Geographic Reach
1 country

35 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Oct 2025Apr 2027

First Submitted

Initial submission to the registry

March 20, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 27, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

October 14, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2027

Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

March 20, 2025

Last Update Submit

March 27, 2026

Conditions

Keywords

chronic insomniaE2R hypnosisemotion-focused therapyprimary caregeneral medicine

Outcome Measures

Primary Outcomes (1)

  • Severity of Insomnia assessed by the Insomnia Severity Index (ISI)

    Insomnia Severity Index (ISI). The minimum score is 0 meaning No Insomnia, the maximum is 28 meaning Severe clinical insomnia

    6 months

Secondary Outcomes (13)

  • Severity of Insomnia assessed by the Insomnia Severity Index (ISI)

    3 months

  • Number of responders assessed by the Insomnia Severity index (ISI)

    3 months

  • Number of responders assessed by the Insomnia Severity index (ISI)

    6 months

  • Number of partial responders assessed by the Insomnia Severity index (ISI)

    3 months

  • Number of partial responders assessed by the Insomnia Severity index (ISI)

    6 months

  • +8 more secondary outcomes

Study Arms (2)

Standard care

ACTIVE COMPARATOR

Patients will receive the usual care offered by their GP, the investigator in the study (except hypnosis).

Other: "Standard care" control group (without hypnosis)

E2R hypnosis

EXPERIMENTAL

4 x 30-minute hypnotherapy sessions over 6 weeks by the hypnotherapist using the E2R method (with self-hypnosis)

Other: Experimental group: "E2R hypnosis"

Interventions

Randomization stratification on insomnia severity. In the "Standard care" group, the investigating physician will not change his or her current practice as part of the study. Treatment will be the same as usual, whether drug-based or not (psychotherapy, etc.), with the exception of hypnosis. The patients will be reviewed at 3 months and 6 months (+/- 1 week) after randomization (D0). The following study information and questionnaires will be completed according to patients' responses: ISI and PSQI self-questionnaires, Record of psychotropic medications, Record of any non-drug therapies implemented, Events that could modify sleep, Serious adverse events (EvIG) and non-serious adverse events (EvING) of a neuropsychiatric nature that occurred or worsened during the study.

Standard care

Randomization stratification on insomnia severity. For the patients randomized to the Hypnosis E2R arm, patients summoned within 15 days to 3 weeks of inclusion for their first hypnotherapy session with the hypnotherapist. All patients will receive 4 hypnotherapy sessions over 6 weeks using the E2R method. The patients will be reviewed at 3 months and 6 months (+/- 1 week) after randomization (D0). The following study information and questionnaires will be completed according to patients' responses: ISI and PSQI self-questionnaires, Record of psychotropic medications, Record of any non-drug therapies implemented, Practice of self-hypnosis requested of the patient (patient diary), Events that could modify sleep, Serious adverse events (EvIG) and non-serious adverse events (EvING) of a neuropsychiatric nature that occurred or worsened during the study.

E2R hypnosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 18 or over,
  • Patient suffering from chronic insomnia according to the DSM-5 definition, whether or not treated with psychotropic drugs:
  • \* At least one of the following sleep disorders: difficulty in falling asleep, difficulty in maintaining sleep, waking up too early and inability to go back to sleep, and \* At least 3 nights a week for at least 3 months, and \* In an adequate night-time sleep context, and \* With at least one significant impact on, or impairment of, social, occupational or behavioral functioning, and \* Insomnia not attributable to the physiological effects of a substance, and \* Insomnia not explicable by a medical condition or mental disorder.
  • Patient willing to undergo hypnotherapy for 4 sessions of 30 min over 6 weeks,
  • Patient whose treating physician is the investigator,
  • Patient able to give free, informed, written consent,
  • Patient affiliated to the French social security system.

You may not qualify if:

  • Patient participating in another study involving the treatment of insomnia or another pathology having an impact on sleep disorders,
  • Patient unable to complete a self-administered questionnaire,
  • Patients with poor or no understanding of the French language,
  • Patients unable to attend hypnotherapy consultations,
  • Deaf or hard-of-hearing patients without hearing aids,
  • Patient under legal protection (safeguard of justice, curatorship, guardianship) or deprived of liberty,
  • Women declaring themselves pregnant or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (35)

Cabinet médical

Bain-de-Bretagne, France

RECRUITING

Cabinet médical de Plaisance

Bouaye, France

RECRUITING

Cabinet médical de Plaisance

Bouaye, France

RECRUITING

Cabinet médical de Breteil

Breteil, France

RECRUITING

Cabinet médical

Cesson-Sévigné, France

RECRUITING

Cabinet médical du Linon

Combourg, France

RECRUITING

Cabinet médical Sycamore

Contres, France

WITHDRAWN

Cabinet médical de Corps Nuds

Corps-Nuds, France

NOT YET RECRUITING

Cabinet médical des Embruns

Crac'h, France

RECRUITING

Pôle Santé Physiomast

Dol-de-Bretagne, France

RECRUITING

MSP de l'Esplanade

Guer, France

RECRUITING

Maison médicale

Iffendic, France

RECRUITING

Cabinet Médical Chantepie

Joué Les Tours, France

RECRUITING

Cabinet Médical de Jugon-Les-Lacs -Saint-Igneuc

Jugon-les-Lacs, France

RECRUITING

Maison médicale des Longrais

La Chapelle-des-Fougeretz, France

RECRUITING

Cabinet médical

La Chapelle-Saint-Ursin, France

RECRUITING

Cabinet médical du Lion d'Or

Nantes, France

RECRUITING

Maison médicale Laennec

Pleudihen-sur-Rance, France

RECRUITING

Maison De Santé De Ronsouze

Ploërmel, France

RECRUITING

Cabinet médical Les Petits Ponts

Pont-Saint-Martin, France

RECRUITING

Cabinet médical Les Petits Ponts

Pont-Saint-Martin, France

RECRUITING

Maison de Santé de Questembert

Questembert, France

RECRUITING

Cabinet médical Olec

Rennes, France

RECRUITING

Cabinet médical

Rennes, France

RECRUITING

Maison médicale pluridisciplinaire

Rouziers-de-Touraine, France

RECRUITING

Maison médical de Maen roch

Saint-Brice-en-Coglès, France

RECRUITING

Maison médicale

Saint-Gilles-Croix-de-Vie, France

RECRUITING

Maison médicale

Saint-Gilles-Croix-de-Vie, France

RECRUITING

Maison de soin du Couesnon

Saint-Ouen-des-Alleux, France

RECRUITING

Cabinet médical

Saint-Romain-sur-Cher, France

RECRUITING

Maison de santé

Sancerre, France

RECRUITING

Cabinet médical de la Blanchisserie

Sully-sur-Loire, France

RECRUITING

Maison de santé

Talensac, France

RECRUITING

Cabinet des médecins généralistes de TIGY

Tigy, France

RECRUITING

Cabinet médical

Vildé-Guingalan, France

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Eric MENER, Ph D

    University of Rennes (Department of general practice)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The HypERR study is a multicenter, randomized, open-label study designed to confirm the efficacy of a hypotherapy method called E2R in the management of chronic insomnia, by comparing it with standard care (without hypnosis)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2025

First Posted

March 27, 2025

Study Start

October 14, 2025

Primary Completion (Estimated)

April 14, 2027

Study Completion (Estimated)

April 14, 2027

Last Updated

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

After informing patients, In accordance : data protection provisions (GDPR and French Data Protection Act) : Intention to share individual data All individual data collected during the study, after pseudonymization and minimization Protocol, amendments, observation log, information sheet and research consent form, statistical analysis plan, statistical analysis code, statistical report, study report without personal data, list of tables, variables and their definitions Data availability : Immediately after publication of the main analysis results and until the database is deleted Data recipients: Project leaders whose reuse has been approved by the sponsor (owner of the study data) and by the study steering committee Types of analyses: Analyses enabling the objectives defined in the sharing agreement to be achieved, which will be drawn up at the time of sharing Access via data request form sent to the promoter and data sharing agreement signed before any data is made available

Locations